WFDC2 and ovarian carcinoma: In the present work, we proposed an innovative approach to address disease diagnosis and management through the integration of IoT home-made portable potentiostat with electrochemical immunosensors for the determination of HE4 as ovarian cancer serological biomarker in the framework of the point-of-care (POC) testing.